In ICB-treated mouse models of orthotopic pMMR CRLM, the proportion of activated CD8+ T cells, CD4+ T cells and cDCs is lower in metastatic tumours than in subcutaneous tumours [211]. The gene discussed is CD8A; the disease is neoplasm.